Ethanol Ablation Using a Multi-pronged Needle and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma: a Randomized Clinical Trial
Patients with early-stage (single tumor no more than 5 cm or up to 3 tumors each no more
than 3 cm in size) primary hepatocellular carcinoma will be randomized into two percutaneous
ablation treatment arms, including radiofrequency ablation and multi-pronged ethanol
ablation. The local treatment responses, complications,and long-term disease-free survivals
and overall survivals are analyzed.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Local treatment responses
Mingde Lu, Prof.
Sun Yat-sen University
China: Ministry of Health